You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Point-of-care immunoassay for early diagnosis of pertussis
SBC: DXDISCOVERY INC Topic: RProject Summary Pertussis is rapidly re emerging as a serious public health threat in the United StatesDespite high vaccine coverage nationallyannual reported cases in the U Shave been increasing recentlywith ayear high ofinMoreoverreported cases represent a large underestimate of pertussis infectionsDiagnosis of early pertussiscatarrhal stageprior to paroxysmal coughis particularly challenging be ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
High Resolution Magnetoencephalography using Atomic Magnetrodes
SBC: QUSPIN INC. Topic: 101DESCRIPTION provided by applicant We propose to develop a small fully integrated ultra sensitive commercial magnetometer that will merge the multi use and cost effective attributes of present EEG electrodes with the sensitivity of SQUID sensors Our device referred to as a magnetrode will combine reliable autonomous operation with straightforward multi channel integration for a robust MEG ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
In Situ Autovaccination against Solid Cancers with Intratumoral Hiltonol Poly ICLC A phase II Adaptive Multicenter Clinical Study
SBC: Oncovir Topic: 102DESCRIPTION provided by applicant Hiltonol poly ICLC is a stabilized dsRNA therapeutic viral mimic or andapos danger signalandapos that activates multiple elements of innate and adaptive immunity It is a standalone immunomodulator but when properly combined with antigen it generates a comprehensive Th weighted immune response best suited for antiviral and antitumor action This project ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Point of care immunoassay for rapid diagnosis of tinea capitis
SBC: DXDISCOVERY INC Topic: NIBIBTinea capitis scalp ringworm is a fungal dermatophyte infection of scalp hair follicles that afflicts of the U S pediatric population Tinea capitis is a major health care disparity because it occurs predominantly among individuals with a disadvantaged socioeconomic background and sub Saharan African descent Diagnosis of tinea capitis is currently dependent on culture and microscopy Both ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A next generation spatial light modulator for mapping of neural networks
SBC: BOULDER NONLINEAR SYSTEMS, INC. Topic: NIBIBBoulder Nonlinear Systems BNS and Prof Edward Boyden s Synthetic Neurobiology Group at the Massachusetts Institute of Technology MIT Media Lab propose to develop a new liquid crystal spatial light modulator SLM capable generating high resolution holograms to overcome the imaging gap that currently divides cellular level optogenetic techniques and whole brain techniques to improve function ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
WayToServe Espanol: A Culturally-Appropriate Online Responsible Beverage Service Training for Spanish-Speaking Servers
SBC: KLEIN BUENDEL, INC. Topic: 102Among the measures against drunk driving available to policy makers and prevention practitionersResponsible Beverage ServiceRBStraining has shown promiseIn these programsalcohol servers are educated in a number of techniquesincluding correct identification checkingrecognizing signs of intoxication in patronsand managing patrons via drink counting techniques to safely keep them under Driving While ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
SBC: INVENUX, LLC Topic: NHLBIDESCRIPTION provided by applicant New therapeutic agents are urgently needed for the treatment of sickle cell disease the worldandapos s most common genetic disease Our long term goal is to develop a botanical drug SCD for use in children and adults that slows or stops disease progression Sickle cell disease affects approximately people in the United States and millions worldw ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of a Non adjuvanted VLP Vaccine against Stealth H N Influenza
SBC: EPIVAX, INC. Topic: NIAIDDESCRIPTION provided by applicant The avian origin H N influenza virus that emerged in humans in China in presents a unique challenge to vaccine development because it is poorly immunogenic Neutralizing antibodies are not detected in acute phase infection Anti H antibody responses are significantly delayed and exhibit low avidity in comparison with antibodies generated following seas ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Development of nucleic acid delivery platform based on polymeric CXCR4 antagonists
SBC: Bohemica Pharmaceuticals, LLC Topic: 100DESCRIPTION provided by applicant Therapeutics based on nucleic acids NA promise to revolutionize treatment of multiple diseases but their widespread use is currently limited by the lack of efficient delivery methods We have recently developed a new NA delivery platform based on polymeric CXCR inhibitors PCX suitable as dual function systems for simultaneous NA delivery and inhibition of ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Innovative Optical System for Hemagglutination Assays
SBC: INDEVR, INC. Topic: NIAIDPROJECT SUMMARY The Hemagglutination assay HA and Hemagglutination Inhibition HI assay are widely used methods for characterizing viruses bacteria and antibodies The World Health Organization recently recommended that HI remain the gold standard method for influenza seroepidemiology Although the HA and HI assays are applied worldwide they have the disadvantages of manual plate reading no ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health